baber/WOPTO huggingface dataset:
Patent CA-3175289-A1 (CA)
Inventor: BRAUON HAIM
IPC: A61M25/01
Filed: 2021-05-12
Abstract: L'invention concerne un système d'administration (p. ex., 200, 300, 1100, 1200, 1300, 1500, 1700, 1800, 1900, 2000, 2100) qui comprend une poignée (p. ex., 900, 1502, 1702, 2002), un corps de cathéter (p. ex., 211, 301, 912, 1004, 1402, 1404, 1504, 1704) et un mécanisme de direction (p. ex., 400, 500, 600, 700, 800, 910, 1000, 1600, 1706, 1901, 2020, 2030). Le corps de cathéter s'étend de la poignée à une partie d'extrémité distale flexible. Le mécanisme de direction est configuré pour diriger la partie d'extrémité distale flexible. Le mécanisme de direction peut comprendre un élément de direction (p. ex., 403, 505, 805, 905, 1304, 1610, 1708, 2026, 3026), un élément de commande (p. ex., 804, 907, 1008, 1506, 1508, 1604, 2008, 2010), et un ou plusieurs éléments d'actionnement (p. ex., 203, 303, 402, 501, 601, 701, 801, 901, 1001, 1101, 1601, 1802, 1910, 2120). L'actionnement de l'élément de commande peut déplacer l'élément de direction pour augmenter et/ou diminuer la tension dans un ou plusieurs éléments d'actionnement.
Patent CA-3176051-A1 (CA)
Title: Acide (s)-2-amino-6-((3-aminopropyl)amino) hexanoique (apl) destine a etre utilise dans le traitement de la steatohepatite non alcoolique (nash), de l'inflammation hepatique, du ballonnement hepatocellulaire, de la fibrose hepatique et de la steatos
Inventor: MERALI SALIM
IPC: C07C229/08
Filed: 2021-04-23
Abstract: L'invention concerne de l'acide (S)-2-amino-6-((3-aminopropyl)amino)hexanoïque (APL) destiné à être utilisé dans le traitement de la stéatohépatite non alcoolique (NASH), de l'inflammation hépatique, du ballonnement hépatocellulaire, de la fibrose hépatique et de la stéatose
Patent CA-3179119-A1 (CA)
Title: Electromagnetically controlled segmented mirror, electromagnetic actuator for use therein and method for manufacturing the same
Inventor: KUIPER STEFAN
IPC: H01F7/06
Filed: 2021-05-27
Abstract: An electromagnetic actuator (1) is disclosed herein comprising a soft- ferromagnetic yoke (10), with an at least substantially cylindrical circumferential wall (11; 11a, 11b, 11c) covered at a first end with a base (12) and at a second end with a top (13), the circumferential wall (11) defining an axis (14) in a direction (14') from said base end to said top. An intermediate yoke section (10b) holds a permanent magnet fixed (20) that leaves an inner space housing an axially movable core element (17) being flexibly restrained with at least one resilient element (18, 19). One of a base yoke section (10a) and/or a top yoke section (10c) houses an electromagnetic coil (16).
Patent CA-3179512-A1 (CA)
Title: Photonics processor architecture
Inventor: HARRIS NICHOLAS C
IPC: G06F17/16
Filed: 2021-04-26
Abstract: Photonic processors are described. The photonic processors described herein are configured to perform matrix multiplications (e.g., matrix vector multiplications). Matrix multiplications are broken down in scalar multiplications and scalar additions. Some embodiments relate to devices for performing scalar additions in the optical domain. One optical adder, for example, includes an interferometer having a plurality of phase shifters and a coherent detector. Leveraging the high-speed characteristics of these optical adders, some processors are sufficiently fast to support clocks in the tens of gigahertz of frequency, which represent a significant improvement over conventional electronic processors.
Patent CA-3181154-A1 (CA)
Inventor: STIDMAN JIMMY
IPC: C04B28/00
Filed: 2022-11-07
Abstract: A system and method, according to one or more exemplary embodiments, for a fireproof, soundproof, lightweight cement and wood composite wall system that is very inexpensive, outlasts wood frame homes, and replaces many building materials in one installation whereby the composite wall system may be formed from wood shavings, cement, calcium chloride, and water rnixed at high speed for air entrainrnent.
Patent CA-3181676-A1 (CA)
Title: Imidazopyridazines as modulators of il-17
Inventor: BEHENNA DOUGLAS
IPC: A61K31/5025
Filed: 2021-04-28
Abstract: The present application discloses compounds having the following formula: (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
Patent CA-3181702-A1 (CA)
Title: Dispositif et procede de detection de dechirure longitudinale d'une bande transporteuse
Inventor: ISHIBASHI YUSUKE
IPC: B65G43/02
Filed: 2021-03-04
Abstract: L'invention concerne un dispositif et un procédé de détection permettant de détecter avec précision la présence ou l'absence d'une déchirure longitudinale dans une bande transporteuse, tout en ayant une polyvalence élevée et un faible coût. Un corps intégré 2, qui a une antenne 4 et une étiquette CI passive 3, connectée à ladite antenne 4, à une extrémité d'un câble coaxial 6 et à l'autre antenne 5 à l'autre extrémité, est incorporé dans une bande transporteuse 17, l'antenne 4 et l'étiquette CI 3 étant espacées de l'autre antenne 5 dans le sens de la largeur et avec le câble coaxial 6 s'étendant dans le sens de la largeur. Une unité de calcul 12 détermine si un détecteur 10 a reçu ou non l'onde radio R2 transmise par l'étiquette CI 3 à travers le câble coaxial 6 et l'autre antenne 5 en réponse à l'onde radio R1 transmise par le détecteur 10 à l'autre antenne 5, et détecte, sur la base du résultat de détermination, la présence ou l'absence d'une déchirure longitudinale dans la bande transporteuse 17 dans la zone où le câble coaxial 6 est incorporé.
Patent CA-3181965-A1 (CA)
Inventor: ACKERMAN PATRICE K
IPC: B32B7/02
Filed: 2022-11-14
Abstract: Composite material protection from UV degradation is disclosed by providing a co-cured composite material substrate co-cured with a UV/visible light-resistant fiberglass layer to form co-cured composite materials for exclusively imparting UV/visible light-resistant properties to co-cured composite material substrates for use in UV/visible light-resistant vehicle fuel tank assemblies.
Patent CA-3182214-A1 (CA)
Title: Indirect measurement system for identifying the position, density and pressure of an underground liquid or gaseous interface
Inventor: MELKI AHMED
IPC: G01N9/00
Filed: 2021-07-07
Abstract: A measuring system for determining a position (h), density (.rho.) and pressure of an underground liquid or gaseous/liquid interface of a gas well or gas reservoir or pressurized tank. The system includes: an instrument panel (10) for measuring data parameters of said underground liquid or gaseous/liquid interface or gas reservoir or pressurized tank in real-time; a control panel (30) operatively connectable to the instrument panel (10) for collecting the data parameters in real-time from the instrument panel (10); and a correction algorithm configured to receive the data parameters and to determine the position, density and pressure of the underground liquid or gaseous/liquid interface or gas reservoir or pressurized tank so as to increase measurement accuracy thereof. Advantageously, a single measuring hydrostatic tube tube is configured to fit into an opening of the gas well.
Patent CA-3185109-A1 (CA)
Title: Fuel cell system and method of operating thereof at near one hundred percent fuel utilization
Inventor: WEINGAERTNER DAVID
IPC: H01M8/0668
Filed: 2022-12-09
Abstract: A fuel cell system includes at least one electrochemical pump separator to separate hydrogen and carbon dioxide from a fuel exhaust stream.
Patent CA-3185955-A1 (CA)
Title: Weightlifting system
Inventor: McGrotty Ryan James
IPC: A63B21/06
Filed: 2023-01-05
Abstract: An exercise system includes a base structure including a first cross brace including first cross brace mounting plates disposed at each end of the first cross brace. A pair of base guide rail supports is secured to and extended substantially orthogonal from the first cross brace and includes a pair of base guide rail receivers. A pair of base pulley supports is secured to and extended substantially orthogonal from the first cross brace and further includes a pulley-support pulley housing. A pair of pulley-support pulleys is rotatably secured to the pulley-support pulley housing. A second cross brace includes a central portion substantially parallel to the first cross brace. The central portion is secured to the pair of base guide rail supports and the pair of base pulley supports. Two end portions are disposed at an angle to the central portion and tenninate at second cross brace mounting plates disposed at each end of the two end portions and two central-portion pulley housings. A central-portion pulley is rotatably secured to each of the two central-portion pulley housings.
Patent CA-3189963-A1 (CA)
Inventor: VILLALBA MARTIN
IPC: A61K35/17
Filed: 2021-08-02
Abstract: The present invention relates to the field of therapeutic treatment, particularly of cell therapy based on CD 16+ cells and NK (Natural Killer) cells. In particular, the invention relates to a pharmaceutical composition comprising a CD 16+ cell, a NK cell or a NK cell precursor, in combination with a recombinant polypeptide comprising a modified Fc region, in particular a modified CH2 domain. More particularly, the invention relates to a composition comprising a CD 16+ cell and/or a NK cell, in combination with a recombinant polypeptide capable of binding to the Fc?RIII (CD 16) surface protein, wherein the recombinant polypeptide is non-covalently bound to the Fc?RIII (CD 16) surface protein expressed by the CD 16+ cell, and wherein said recombinant polypeptide comprises: (i) a modified CH2 domain of a wild-type human IgGl, bound, optionally through a linker, to (ii) a ligand binding domain, wherein the ligand binding domain comprises a sequence capable of binding to a target ligand; wherein the modified CH2 domain is characterized by comprising mutations S239D and I332E with respect to the CH2 domain of a wild-type human IgG1, and wherein said CH2 domain of a wild-type human IgG1 is represented by SEQ ID NO 1, and comprises sequence positions 231-340, according to the EU numbering.
Patent CA-3195557-A1 (CA)
Title: Procede d'hydrodesulfuration d'une coupe essence mettant en oeuvre un catalyseur contenant un materiau graphitique caracterise par son rapport h/c
Inventor: DEVERS ELODIE
IPC: C10G45/06
Filed: 2021-11-18
Abstract: L'invention concerne un procédé d'hydrodésulfuration d'une coupe essence dans lequel on met en contact ladite coupe essence, de l'hydrogène et un catalyseur, ledit catalyseur comprend un support d'oxyde, du soufre et une phase active comprenant au moins un métal du groupe VI B et au moins un métal du groupe VIII, ledit catalyseur contenant entre outre un matériau graphitique contenant du carbone et de l'hydrogène, la teneur en carbone, exprimée en élément carbone, étant comprise entre 5 et 20 % pds par rapport au poids du catalyseur et le rapport atomique H/C est inférieur à 1,4, ledit matériau graphitique ne contenant pas d'oxygène.
Patent CA-3196564-A1 (CA)
Inventor: LIU HANLAN
IPC: C07D487/04
Filed: 2021-10-28
Abstract: The present disclosure relates to: a) solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III); b) pharmaceutical compositions comprising one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III), and optionally, a pharmaceutically acceptable carrier or diluent; c) methods of treating tumors or cancers by administering one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III) to a subject in need thereof; and d) methods for the preparation of solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III).
Patent CA-3197537-A1 (CA)
Title: Anticorps contre les virus de la grippe a
Inventor: CORTI DAVIDE
IPC: A61P31/16
Filed: 2021-11-19
Abstract: La présente divulgation concerne des anticorps et leurs fragments de liaison à l'antigène qui peuvent se lier à une hémagglutinine (HA) du virus de la grippe A (IAV) et qui peuvent neutraliser une infection par l'IAV. La divulgation concerne également des polynucléotides qui codent pour un anticorps ou un fragment de liaison à l'antigène, des vecteurs qui comprennent de tels polynucléotides, des cellules hôtes qui peuvent exprimer les anticorps ou les fragments de liaison à l'antigène, des compositions associées et des méthodes d'utilisation des compositions divulguées dans la description pour, par exemple, traiter ou prévenir une infection par l'IAV.
Patent CA-3201712-A1 (CA)
Title: Textiles touffetes multicolores et leurs procedes de production
Inventor: BEAVERS GEOFFREY
IPC: A47G27/02
Filed: 2021-12-15
Abstract: La présente divulgation concerne des produits textiles touffetés multicolores et leurs procédés de production.
Patent CA-3202046-A1 (CA)
Inventor: VAN DIJK EDWARD JOHN HENRIK
IPC: C02F3/30
Filed: 2021-12-10
Abstract: The invention pertains to a method for the purification of substrate-containing wastewater in a continuous flow-through aerobic biologically activated sludge reactor B, wherein at least part of biological sludge 6 is conditioned in a selector S under anaerobic or anoxic conditions with at least part of the substrate-containing, to-be-purified wastewater 2, optionally after a pre-treatment step VB of the supplied wastewater 1, such that at least 20 wt% of the sludge in the selector S has a residence time in the selector which is at least 20% greater than the hydraulic residence time of the sludge/water mixture in the selector, after which the thus conditioned sludge/water mixture 3, optionally after an additional anaerobic or anoxic contact step, is fed to the aerobic purification reactor B and subjected to aerobic treatment B, wherein the treated wastewater 4 after aerobic treatment is optionally separated from the sludge by settling NB, flotation or mechanical separation, and wherein (at least a portion of) the sludge separated from the aerobically treated wastewater is returned to the selector as return sludge 6.
Patent CA-3202503-A1 (CA)
Inventor: BAUMNER ANTJE
IPC: G01N33/543
Filed: 2021-12-22
Abstract: La présente invention porte sur un ensemble de particules permettant de détecter une molécule de neutralisation d'agents pathogènes. La présente invention porte en outre sur une composition comprenant un ensemble de particules. La présente invention porte également sur une méthode de détection d'une molécule de neutralisation d'agents pathogènes. En outre, la présente invention porte sur un kit de détection d'une molécule de neutralisation d'agents pathogènes. La présente invention porte en outre sur un dispositif de point d'intervention, et une utilisation d'un ensemble de particules ou d'une composition dans une méthode de détection d'une molécule de neutralisation de pathogènes.
Patent CA-3202638-A1 (CA)
Title: Compositions de revetement electrodeposables resistant au phosphate
Inventor: BROWN-TSENG ELIZABETH STEPHENIE
IPC: C08G18/08
Filed: 2021-12-30
Abstract: La présente invention concerne une composition de revêtement électrodéposable comprenant un liant électrodéposable comprenant un polymère filmogène contenant un groupe de sel ionique comprenant des groupes fonctionnels hydrogène actif, et un agent de durcissement polyisocyanate bloqué ; un catalyseur au bismuth solubilisé ; et une guanidine ; la composition de revêtement électrodéposable ayant un rapport en poids de métal de bismuth du catalyseur au bismuth solubilisé sur la guanidine de 1,00/0,071 à 1,0/2,1 et/ou un rapport molaire du métal de bismuth sur la guanidine de 1,0/0,25 à 1,0/3,0. L'invention concerne également des procédés de traitement de compositions de revêtement électrodéposables, des procédés de fabrication de compositions de revêtement électrodéposables, des systèmes de revêtement d'un substrat métallique, des revêtements, des substrats revêtus et des procédés de revêtement d'un substrat.
Patent CA-3202904-A1 (CA)
Title: Plant growth-promoting bacillus thuringiensis strain and uses thereof
Inventor: BULLIS DAVID T
IPC: C05G3/60
Filed: 2012-12-13
Abstract: An enriched culture of microbial strain SGI-020-A01 deposited as NRRL B-50484 useful for enhancing plant growth and/or suppressing the development of plant pathogens and pathogenic diseases.
Patent CA-3203004-A1 (CA)
Title: Methods and systems for the detection of microorganisms using infectious agents
Inventor: ERICKSON STEPHEN E
IPC: G01N33/569
Filed: 2021-11-23
Abstract: Disclosed herein are methods, compositions, kits, and systems for rapid detection of a microorganism of interest on a surface, including medical devices. Cocktail compositions of recombinant bacteriophages can be used to detect potentially harmful bacteria. The specificity of recombinant bacteriophages for binding microorganisms allows targeted and highly specific detection of a microorganism of interest.
Patent CA-3203694-A1 (CA)
Title: Vaseline a base d'huile naturelle et son procede de fabrication
Inventor: EVERAERT EMMANUEL PAUL JOS MARIE
IPC: A61K8/85
Filed: 2022-01-05
Abstract: L'invention concerne des compositions de vaseline à base d'huile naturelle et un procédé de fabrication de celles-ci. La composition de vaseline à base d'huile naturelle comprend le produit d'estérification de : environ 0,1 % en poids à environ 35 % en poids d'un dimère d'acide gras, environ 5 % en poids à environ 30 % en poids d'un acide gras en C8 à C22 et environ 65 % en poids à environ 95 % en poids d'huile naturelle hydrogénée, le produit de vaseline à base naturelle ayant un indice d'acide inférieur à 25. Des compositions de vaseline à base d'huile naturelle peuvent être utilisées dans des produits de soins personnels.
Patent CA-3205559-A1 (CA)
Title: Hydraulically-bonded multilayer panel
Inventor: WERNER VOLKMAR
IPC: C04B28/08
Filed: 2020-12-29
Abstract: The invention relates to a method for producing a hydraulically bound multilayer panel comprising at least one facing layer and at least one core layer. The method has the following steps: a. introducing a flowable facing mixture into a mold, said facing mixture containing at least the following components: i. an facing glue containing at least 1. a hydraulic binder and 2. water; and ii. an aggregate, said aggregate having an average diameter d50 which is greater than or equal to 100.0 µm, determined according to ISO 13320:2009 and/or EN 12620, whereby an facing mixture layer is formed; b. introducing a dried to earth-moist core mixture into the mold, wherein the core mixture contains at least the following components: i core glue containing at least 1. a hydraulic binder, 2. a fine material, said fine material having an average diameter d50 of up to 100.0 µm, determined according to ISO 13320:2009, and 3. water; and ii. an aggregate, said aggregate having an average diameter d50 which is greater than 100.0 µm, determined according to ISO 13320:2009 and/or EN 12620; whereby a core mixture layer is formed, and c. compressing the facing mixture layer together with the core mixture layer in the mold in order to form a hydraulically bound multilayer panel which can be directly stripped and which comprises at least one facing layer and at least one core layer, wherein water contained in the facing mixture layer is partly or completely pressed into the core mixture layer.
Patent CA-3206729-A1 (CA)
Title: Systems and methods for federated learning using peer-to-peer networks
Inventor: BEHERA MONIK RAJ
IPC: G06N20/20
Filed: 2022-02-01
Abstract: Systems and methods for federated learning using peer-to-peer networks are disclosed. A method may include: electing a participant node as a collaborator node using a consensus algorithm; the collaborator node generating and broadcasting a public/private key pair; the participant nodes generating public/private key pairs for each communication with the collaborator node, encrypting and broadcasting a message comprising a parameter for a local machine learning model for the participant node and its public key with the collaborator node's public key, the collaborator node decrypting the encrypted messages, updating an aggregated machine learning model with the decrypted parameters, encrypting and broadcasting update messages each comprising an update with each participant node's public key; the participant nodes decrypting one of the messages with their private keys, and the participant nodes updating their local machine learning models with the update.
Patent CA-3207947-A1 (CA)
Inventor: NOYES AARON
IPC: A61K47/69
Filed: 2022-02-17
Abstract: The present disclosure relates to extracellular vesicles (e.g., exosomes) comprising a biologically active molecule covalently linked to the extracellular vesicle via an optimized linker and an anchoring moiety, which may be useful as an agent for the prophylaxis or treatment of cancer or other diseases. Also provided herein are methods for producing the extracellular vesicles and methods for using the extracellular vesicles to treat diseases or disorders.
Patent CA-3208556-A1 (CA)
Title: Universal chips dispenser
Inventor: KAMBLE RAHUL SADASHIV
IPC: G07F13/02
Filed: 2022-02-15
Abstract: A universal snack dispenser capable of providing crisp snacks to customers offers a touchless experience and delivers a sufficient amount of the snacks independent of the type and container.
Patent CA-3209639-A1 (CA)
Title: Systemes de transposon associes a crispr et leurs procedes d'utilisation
Inventor: WATTERS KYLE EDWARD
IPC: C07K14/195
Filed: 2022-01-28
Abstract: La présente invention concerne des systèmes, des compositions et des procédés pour modifier des séquences d'acides nucléiques cibles.
Patent CA-3210339-A1 (CA)
Title: Improved method for regenerating reduced forms of enzyme cofactors
Inventor: DODDS DAVID
IPC: C12P19/36
Filed: 2022-01-31
Abstract: Provided herein are composition and process for using a device for the reduction of the oxidized state of phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide to the reduced state, using a catalyst to enable the reduction of the oxidized form of the phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide by hydrogen, and methods for providing the hydrogen.
Patent CA-3212994-A1 (CA)
Inventor: GODFREY CAROLINE
IPC: A61K47/64
Filed: 2022-03-11
Abstract: Des méthodes de traitement d'un sujet ayant une dystrophie myotonique de type 1 (DM1) sont divulguées. Les méthodes comprennent l'administration d'un schéma thérapeutique comprenant une pluralité de doses d'un conjugué espacé à un intervalle de temps d'au moins 1 mois, le conjugué comprenant un oligonucléotide et un peptide lié de manière covalente ou lié par l'intermédiaire d'un lieur à l'oligonucléotide, le peptide comprenant un domaine hydrophobe flanqué de deux domaines cationiques, chacun des domaines cationiques comprenant l'un parmi RBRRBRR (SEQ ID No : 1), RBRBR (SEQ ID No : 2), RBRR (SEQ ID No : 3), RBRRBR (SEQ ID No : 4), RRBRBR (SEQ ID No : 5), RBRRB (SEQ ID No : 6), BRBR (SEQ ID No : 7), RBHBH (SEQ ID No : 8), HBHBR (SEQ ID No : 9), RBRHBHR (SEQ ID No : 10), RBRBBHR (SEQ ID No : 11), RBRRBH (SEQ ID No : 12) HBRRBR (SEQ ID No : 13), HBHBH (SEQ ID No : 14), BHBH (SEQ ID No : 15), BRBSB (SEQ ID No : 16), BRB[Hyp]B (SEQ ID No : 17), R[Hyp]H[Hyp]HB (SEQ ID No : 18) et R[Hyp]RR[Hyp]R (SEQ ID No : 19) et le domaine hydrophobe comprenant l'un parmi YQFLI (SEQ ID No : 20), FQILY (SEQ ID No : 21), ILFQY (SEQ ID No : 22), FQIY (SEQ ID No : 23), VWVW, WWPWW (SEQ ID No : 24), WPWW (SEQ ID No : 25) et VWVPW (SEQ ID No : 26). L'oligonucléotide comprend un total de 12 à 40 nucléobases contiguës, au moins 9 nucléobases contiguës étant complémentaires d'une séquence de répétition CUG.
Patent CA-3214753-A1 (CA)
Title: Dosing of bispecific t cell engager
Inventor: SMITH VICTORIA
IPC: C07K16/28
Filed: 2022-04-08
Abstract: Methods for reducing myeloid-derived suppressor cells and activating T cells in a patient and for treating a patient suffering from a solid tumor are described. The methods entail administering a CD3/CD33 T cell engager.